Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CytoSorb in Cardiac Surgery
NCT02666703Phase 3Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: Evolution of pro-inflammatory and anti-inflammatory cytokines at 5 days, Evolution of complement C5a at 5 days and 3 more. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02666703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666703.